Data from the COLUMBUS trial.

Prospective analysis of 453,655 Koreans over the course of 12 years.

Longer treatment yields better outcomes.

Impressive efficacy ongoing at 5 years.

Effect driven at least in part by modulation of tryptophan metabolism.

Comparative benefit seen at 2 years, but not after 5 years.

Trials with a commercial sponsor were substantially more likely to post results than those with a non-commercial sponsor.

Members of the European Parliament say the growing threat posed by antibiotic-resistant bacteria should be tackled through a “One Health” approach.

Findings from the first systematic review and meta-analysis to examine the anxiolytic effects of omega-3 fatty acids.

Four liters of clear liquids proposed as standard method.

Better understanding of prognostic factors can help guide patient management.

Association calls for gender-affirming, nonjudgmental approach.

Exploratory analysis of SPARTAN trial.

Schedules are primary care's major challenge to vaccination rates.